SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Medicago starts human trial for H5N1 bird flu vaccine MDG

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
From: bcjt10/20/2009 12:58:06 PM
   of 2
 
Medicago appoints Johnson to board

2009-10-19 07:21 MT - News Release

Mr. Andy Sheldon reports

FORMER PREMIER OF QUEBEC PIERRE MARC JOHNSON JOINS MEDICAGO'S BOARD OF DIRECTORS

Medicago Inc. has appointed Pierre Marc Johnson, attorney, physician and former premier of Quebec, to its board of directors. Mr. Johnson replaces Damien Levesque, who is leaving the board of Medicago after serving for nine years. Mr. Levesque will continue to assist Medicago as a consultant. "We are pleased to welcome Mr. Johnson to medicago's Board," said Dr. Randal Chase, chairman of the Medicago board of directors. "As one of Quebec's prominent leaders, Mr. Johnson brings a wealth of strategic insight and solid experience working in governments and businesses. His knowledge of public policy and regulatory processes as well as business activities will make of Mr. Johnson a great asset to Medicago in the future development and commercialization of its novel influenza vaccines." "On behalf of the board, I would like to thank Mr. Levesque for his great dedication and loyal service to Medicago since the inception of the company. His guidance was of great assistance to the development of our business," concluded Dr. Chase.

Mr. Johnson is a lawyer, physician, former premier of Quebec and former professor of law at McGill University. He has been of counsel with the offices of Heenan Blaikie LLP since 1996. He is recognized for his expertise in international trade negotiations and international partnerships as well as environmental and health law. From 1976 to 1987, he was a member of the Quebec Legislature Assembly and in senior cabinet positions before becoming premier in 1985. He was a founding Vice-Chair of the prime minister's National Round Table on the Environment and the Economy of Canada, chaired its foreign policy committee for seven years. He also served as a special adviser to the secretary general of the United Nations Conference on Environment and Development (UNCED) and to the North American Commission on Environmental Cooperation. Mr. Johnson was a director of several major corporations and currently sits on the boards of ACE Aviation Holdings Corporation, Air Canada and Holcim Canada; he chairs the foresight committee of the Veolia Institute for the Environment of Paris. In 2006, he was appointed chair of the board of directors of the Quartier de la Sante; (Health district corporation), a Montreal-based organization created to foster diagnostic and therapeutic innovation. Mr. Johnson holds an honorary doctorate from the University; Claude Bernard Lyon I, France. He is fellow of the Royal Society of Canada, grand officier of the Ordre de la Peiade and grand officer of the Ordre National du Quebec. Concurrently with his appointment, Mr. Johnson was granted 37,500 options at an exercise price of 60 cents. Said options are governed by the stock options plan of the company and will vest in three yearly installments.

We seek Safe Harbor.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext